RT Journal Article
SR Electronic
T1 Rare variant aggregation highlights rare disease genes associated with brain volume variation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.26.24314187
DO 10.1101/2024.09.26.24314187
A1 Wightman, Douglas P.
A1 Maciel, Bernardo A.P.C.
A1 Brouwer, Rachel M.
A1 van den Heuvel, Martijn P.
A1 Posthuma, Danielle
YR 2024
UL http://medrxiv.org/content/early/2024/09/28/2024.09.26.24314187.abstract
AB Variation in brain volume is associated with common and rare disorders. Investigating the genetics of brain volume may highlight overlap between diseases and biological mechanisms that explain disease symptoms. Previous studies examining genetic variants associated with brain volume have largely focused on common variants, with rare variant studies not primarily focusing on brain volume phenotypes or focusing on large structural variants. In this study, we aggregated rare variants within genes and associated genes with 44 brain volume phenotypes in the UK Biobank (N=40,374). We found convergence between genes within the same biological pathway and convergence between common and rare variants within the same gene. Seven of the genes associated with total or regional brain volume measures were also linked with rare brain disorders in previous literature. We successfully showed that rare variants in genes linked to rare brain disorders were also associated with sub-clinical brain volume variation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDP was funded by The Netherlands Organization for Scientific Research (NWO VICI 453-14-005), NWO Gravitation: BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology (Grant No. 024.004.012), and a European Research Council advanced grant (Grant No, ERC-2018-AdG GWAS2FUNC 834057). DW was funded by NWO Gravitation: BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology (Grant No. 024.004.012). BAPCM was funded by NWO Gravitation: BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology (Grant No. 024.004.012). MPvdH was supported by NWO VIDI Grant 452-16-015 and the ERC Consolidator of the European Research Council Grant 101001062. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UKB received ethical approval from the National Research Ethics Service Committee North West-Haydock (reference 11/NW/0382).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes